Treatment of Drug-Susceptible Tuberculosis

被引：9
|
作者：
Dela Cruz, Charles S. [1 ]
Lyons, Patrick G. [2 ]
Pasnick, Susan [3 ]
Weinstock, Tanya [4 ,5 ]
Nahid, Payam [3 ]
Wilson, Kevin C. [6 ]
Thomson, Carey C. [4 ,5 ]
机构：
[1] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA
[2] Univ Chicago, Pritzker Sch Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA
[3] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
[4] Mt Auburn Hosp, Div Pulm Dis & Crit Care Med, Cambridge, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Boston Univ, Med Ctr, Div Allergy Pulm Crit Care & Sleep Med, Boston, MA USA
来源：
ANNALS OF THE AMERICAN THORACIC SOCIETY | 2016年 / 13卷 / 11期
关键词：
D O I：
10.1513/AnnalsATS.201607-567CME
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2060 / 2063
页数：4
相关论文
共 50 条
  • [31] Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis
    Lee, Hyun
    Sohn, Jang Won
    Sim, Yun Su
    Shin, Tae Rim
    Kim, Dong-Gyu
    Choi, Hayoung
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [32] Treatment success and related factors of drug-susceptible and drug-resistant tuberculosis patients in Aceh referral hospital
    Maulina, Novi
    Hayati, Zinatul
    Zulkarnain, Zulkarnain
    Hasballah, Kartini
    Waraztuty, Ika
    [J]. PHARMACY EDUCATION, 2023, 23 (04): : 289 - 293
  • [33] Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis
    Velasquez, Gustavo E.
    Nahid, Payam
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (07) : 816 - 818
  • [34] Outcomes of Extended Duration Therapy for Drug-Susceptible Cavitary Pulmonary Tuberculosis
    Choi, H.
    Lee, H.
    Sim, Y.
    Shin, T.
    Kim, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [35] Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis
    Munoz-Torrico, M.
    Cid-Juarez, S.
    Gochicoa-Rangel, L.
    Torre-Bouscolet, L.
    Salazar-Lezama, M. A.
    Villarreal-Velarde, H.
    Perez-Padilla, R.
    Visca, D.
    Centis, R.
    D'Ambrosio, L.
    Spanevello, A.
    Saderi, L.
    Sotgiu, G.
    Migliori, G. B.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (07) : 700 - +
  • [36] Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient
    Baffoe-Bonnie, Anthony
    Houpt, Eric R.
    Turner, Lauren
    Dodge, Denise
    Heysell, Scott K.
    [J]. EMERGING INFECTIOUS DISEASES, 2019, 25 (11) : 2120 - 2121
  • [37] Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis
    Theron, G.
    Smith, L.
    Limberis, J. D.
    Venter, R.
    Esmail, A.
    McNerney, R.
    Calligaro, G. L.
    Fennelly, K. P.
    Warren, R. M.
    Dheda, K. U. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [38] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis
    Deng, Guofang
    Fu, Liang
    [J]. LANCET INFECTIOUS DISEASES, 2024, 24 (09): : 940 - 941
  • [39] Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study
    Chida, Natasha
    Ansari, Zara
    Hussain, Hamidah
    Jaswal, Maria
    Symes, Stephen
    Khan, Aamir J.
    Mohammed, Shama
    [J]. PLOS ONE, 2015, 10 (11):
  • [40] Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India
    Kalva, Jayashree
    Babu, Senbagavalli P.
    Narasimhan, Prakash B.
    Raghupathy, Kalaivani
    Ezhumalai, Komala
    Knudsen, Selby
    Horsburgh, Charles R.
    Hochberg, Natasha
    Salgame, Padmini
    Roy, Gautam
    Ellner, Jerrold
    Sarkar, Sonali
    [J]. JOURNAL OF PUBLIC HEALTH, 2022, : 545 - 552
12345